Cardiol Therapeutics (CRDL)
(Delayed Data from NSDQ)
$1.98 USD
-0.05 (-2.46%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Cardiol Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.84 | -23.79 | -25.24 | NA | NA |
Depreciation/Amortization & Depletion | 0.18 | 0.17 | 0.18 | NA | NA |
Net Change from Assets/Liabilities | -0.40 | 4.42 | 0.06 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 2.40 | -1.73 | 6.22 | NA | NA |
Net Cash From Operating Activities | -18.65 | -20.94 | -18.79 | NA | NA |
Property & Equipment | -0.05 | -0.06 | -0.01 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 0.00 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | -0.05 | -0.06 | -0.01 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 78.78 | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | -0.04 | -0.04 | -0.04 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | 0.00 | 0.00 | -4.18 | NA | NA |
Net Cash from Financing Activities | -0.04 | -0.04 | 74.55 | NA | NA |
Effect of Exchange Rate Changes | 0.56 | 2.25 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | -18.18 | -18.79 | 55.75 | NA | NA |
Cash at Beginning of Period | 44.06 | 64.54 | 11.19 | NA | NA |
Cash at End of Period | 25.88 | 45.74 | 66.94 | NA | NA |
Diluted Net EPS | -0.33 | -0.38 | -0.58 | NA | NA |
Fiscal Year End for Cardiol Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -11.52 | -6.80 | -20.84 | -15.27 | -10.83 |
Depreciation/Amortization & Depletion | 0.09 | 0.05 | 0.18 | 0.14 | 0.09 |
Net Change from Assets/Liabilities | 0.55 | -0.02 | -0.40 | -1.55 | -1.42 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.34 | 1.65 | 2.40 | 2.74 | 0.78 |
Net Cash From Operating Activities | -8.55 | -5.13 | -18.65 | -13.95 | -11.38 |
Property & Equipment | -0.01 | 0.00 | -0.05 | -0.04 | -0.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | 0.00 | -0.05 | -0.04 | -0.04 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.13 | 0.07 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.02 | -0.01 | -0.04 | -0.03 | -0.02 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.11 | 0.06 | -0.04 | -0.03 | -0.02 |
Effect of Exchange Rate Changes | 0.47 | 0.36 | 0.56 | -0.09 | 0.63 |
Net Change In Cash & Equivalents | -7.97 | -4.71 | -18.18 | -14.11 | -10.81 |
Cash at Beginning of Period | 25.52 | 25.89 | 44.06 | 44.32 | 44.23 |
Cash at End of Period | 17.55 | 21.18 | 25.88 | 30.21 | 33.43 |
Diluted Net EPS | -0.07 | -0.10 | -0.09 | -0.07 | -0.09 |